Search clinical trials for: MK0686

Total 141 results

Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)

Hypertension
Merck Sharp & Dohme LLC

Terminated

A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

Neuralgia, Postherpetic
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)

Osteoarthritis
Merck Sharp & Dohme LLC

Completed

MK0686 in Postsurgery Dental Pain (0686-002)

Pain, Postoperative
Merck Sharp & Dohme LLC

Terminated

A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)

Neoplasms
Merck Sharp & Dohme LLC

Completed

The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)

Atherosclerosis
Merck Sharp & Dohme LLC

Terminated

Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)

Hip Fracture

Germany, Norway, Spain, Sweden, United Kingdom
Merck Sharp & Dohme LLC

Completed

Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

Alzheimer's Disease
Merck Sharp & Dohme LLC

Completed

MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028)

Asthma
Merck Sharp & Dohme LLC

Completed

MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)

Diabetes Mellitus, Type 2 | Metabolic Syndrome
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019)

Asthma
Merck Sharp & Dohme LLC

Completed

Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)

Asthma
Merck Sharp & Dohme LLC

Terminated

MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)

HIV-1 Infection
Merck Sharp & Dohme LLC

Terminated

The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

Asthma
Merck Sharp & Dohme LLC

Completed

A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013)

Breast Cancer
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)

Urinary Tract Infection
Hillel Yaffe Medical Center

Unknown

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer

Ovarian Cancer

Israel
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)

Cancer, Advanced
Merck Sharp & Dohme LLC

Completed

A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED)

Advanced Cancer Relapsed | Advanced Cancer Refractory
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)

Urinary Tract Infection
Merck Sharp & Dohme LLC

Completed

MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)

Duodenal Ulcer | Stomach Ulcer
Merck Sharp & Dohme LLC

Terminated

12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003)

Arthritis, Rheumatoid | Osteoarthritis
Merck Sharp & Dohme LLC

Completed

An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)

B-cell Lymphoma
Merck Sharp & Dohme LLC

Completed

Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)

Mycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma
Merck Sharp & Dohme LLC

Completed

Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))

Multiple Myeloma
Merck Sharp & Dohme LLC

Terminated

A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)

Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC

Terminated

Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)

Urinary Tract Infections
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

Sepsis
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)

Pneumonia | Urinary Tract Infection | Infection
Merck Sharp & Dohme LLC

Terminated

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)

Multiple Myeloma
Merck Sharp & Dohme LLC

Completed

A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)

Colorectal Surgery
Organon and Co

Completed

Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)

Lipid Metabolism Disorder
Organon and Co

Completed

A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)

Acute Pain Following a Total Abdominal Hysterectomy
Organon and Co

Completed

Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)

Hypercholesterolemia
Organon and Co

Completed

Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

Hypercholesterolemia
Organon and Co

Completed

Sitosterolemia Extension Study (0653-004)(COMPLETED)

Heart Disease | Lipid Metabolism, Inborn Errors
Organon and Co

Completed

Sitosterolemia Extension Study (0653-003)(COMPLETED)

Heart Disease | Lipid Metabolism, Inborn Errors
Organon and Co

Completed

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

Coronary Disease | Hypercholesterolemia
Organon and Co

Completed

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Coronary Disease | Hypercholesterolemia
Organon and Co

Completed

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

Coronary Disease | Hypercholesterolemia
Organon and Co

Completed

An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)

Dysmenorrhea
Organon and Co

Completed

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

Coronary Disease | Hypercholesterolemia
Organon and Co

Completed

An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

Heart Disease | Lipid Metabolism, Inborn Errors
Organon and Co

Completed

Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)

Hypercholesterolemia
Organon and Co

Completed

Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)

Hypercholesterolemia
Organon and Co

Completed

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Hypercholesterolemia | Hypertriglyceridemia
Organon and Co

Completed

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

Hypercholesterolemia | Hypertriglyceridemia
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

Complicated Intra-abdominal Infection
Merck Sharp & Dohme LLC

Completed

Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)

Urinary Tract Infections | Soft Tissue Infections | Bacterial Pneumonia
Merck Sharp & Dohme LLC

Completed

Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors

Advanced Cancer

3

Subscribe